The 13th Annual Meeting of the Asian Organization for Crohn’s and Colitis（AOCC2025）

*AYAKO FUCHIGAMI¹, Rie Irie¹, Naruaki Matsui¹, Takeshi Ichikawa¹ (1. Nippon Koukan Hospital)

*Yusuke Ozeki¹, Takashi Taida¹, Yuki Ohta¹, Toshiyuki Ito¹, Takuya Ohashi¹, Tomomi Ozaki¹, Yoshiki Matsubara¹, Shohei Mukai¹, Yushi Koshibu¹, Nobuaki Shu¹, Makoto Furuya¹, Yuhei Ohyama¹, Hayato Nakazawa¹, Yukiyo Mamiya¹, Chihiro Goto¹, Ryosuke Horio¹, Satsuki Takahashi¹, Akane Kurosugi¹, Michiko Sonoda¹, Wataru Shiratori², Tsubasa Ishikawa¹, Tatsuya Kaneko¹, Kenichiro Okimoto¹, Keiko Saito¹, Tomoaki Matsumura¹, Jun Kato¹ (1. Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., 2. Department of Gastroenterology, Fukaya Red Cross Hospital.)

*Rui Zhong¹, Yufang Wang¹ (1. Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University)

*Jiaming Zhou¹, Jian Wan¹, Zhuo Wang¹, Hao Zhang¹, Kaichun Wu¹ (1. First Affiliated Hospital of Air Force Medical University)

*Shoko Arimitsu¹, Hiroaki Ito¹ (1. Kinshukai Infusion Clinic)

*Yang Yang^1,2,3,4, Xingyang Luo^1,2,3,4, Linxiang Zhou^1,2,3, Guanzhong Shi⁴, Ying Xiao^1,2,3, Xiaowei Liu^1,2,3 (1. Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China, 2. Hunan International Scientific and Technological Cooperation Base of Artificial Intelligence Computer Aided Diagnosis and Treatment for Digestive Disease, Changsha, Hunan, China, 3. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China, 4. Xiangya School of Medicine, Central South University, Changsha, Hunan, China)

*Ao Liu¹, Xiaohua Hou¹ (1. Huazhong University of Science and Technology)

*Wen Zhou¹, Christopher Ma², Sami Hoque³, Miles P. Sparrow⁴, Jaclyn K. Anderson¹, Mark Yen⁵, Bin Dong¹, Brian G. Feagan⁶, Bruce E. Sands⁷ (1. Merck & Co., Inc., Rahway, NJ, USA, 2. Division of Gastroenterology & Hepatology, Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada, 3. Department of Gastroenterology, Barts Health NHS Trust, London, UK, 4. Department of Gastroenterology, School of Translational Medicine, Monash University and Alfred Health, Melbourne, VIC, Australia, 5. Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, 6. Departments of Medicine, Epidemiology, and Biostatistics, Western University, London, ON, Canada, 7. Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA)

*Wen Zhou¹, Corey A. Siegel², Rupert W. Leong³, Jaclyn K. Anderson¹, Mark Yen¹, Bin Dong¹, Bruce E. Sands⁴, Silvio Danese⁵, Brian G. Feagan⁶ (1. Merck & Co., Inc., Rahway, NJ, USA, 2. Dartmouth-Hitchcock Inflammatory Bowel Disease Center, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 3. Concord Hospital and Macquarie University Hospital, Sydney, NSW, Australia, 4. Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA, 5. Humanitas Clinical and Research Center - IRCCS, Rozzano and Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Milan, Italy, 6. Department of Medicine, Division of Gastroenterology, Western University, London, ON, Canada)